P3 Health Partners Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 285.15 million compared to USD 243.99 million a year ago. Revenue was USD 288.35 million compared to USD 248.26 million a year ago. Net loss was USD 13.3 million compared to USD 11.17 million a year ago. Basic loss per share from continuing operations was USD 0.12 compared to USD 0.27 a year ago. Diluted loss per share from continuing operations was USD 0.12 compared to USD 0.27 a year ago.
For the nine months, sales was USD 909.47 million compared to USD 780.78 million a year ago. Revenue was USD 919.51 million compared to USD 791.26 million a year ago. Net loss was USD 32.31 million compared to USD 176.1 million a year ago. Basic loss per share from continuing operations was USD 0.37 compared to USD 4.24 a year ago. Diluted loss per share from continuing operations was USD 0.41 compared to USD 4.27 a year ago.